Drug-induced lupus erythematosus: an update on drugs and mechanisms

Y He, AH Sawalha - Current opinion in rheumatology, 2018 - journals.lww.com
The list of drugs implicated in triggering DILE is expanding as new drugs with novel
mechanisms of action are being developed. It is important to recognize culprit drugs that …

Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases

KM Kingsmore, AC Grammer, PE Lipsky - Nature Reviews …, 2020 - nature.com
The past century has been characterized by intensive efforts, within both academia and the
pharmaceutical industry, to introduce new treatments to individuals with rheumatic …

Cutaneous drug-induced lupus erythematosus: clinical and immunological characteristics and update on new associated drugs

P Bataille, F Chasset, JB Monfort… - … de Dermatologie et de …, 2021 - Elsevier
Cutaneous drug-induced lupus erythematosus (CDILE) is a lupus-like syndrome related to
drug exposure which typically resolves after drug discontinuation. It can present as a …

Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report

K Xu, M Zhang, S Yang, G Yu, P Zheng, X Qin, J Feng - BMC neurology, 2023 - Springer
Background Teriflunomide, the active metabolite of leflunomide, is a disease-modifying
therapy drug used for the treatment of multiple sclerosis (MS), yet the complications …

Predictors of minimal, moderate, and major response to Belimumab evaluated by CLASI, DAS28 and SLE-DAS. A retrospective analysis of a large nationwide …

R PROSPERO - thesis.unipd.it
Background. Systemic lupus erythematosus is an autoimmune disease involving skin and
joints. Belimumab is the first biological drug approved for SLE. Aim. The aim of this study …

[PDF][PDF] Cefotaxime Induced Staphylococcal Scalded Skin Syndrome: A Case Report

S Jakkula, S Chinnala, S Komuravelly… - Indian Journal of …, 2021 - ijopp.org
ABSTRACT Staphylococcal Scalded Skin Syndrome (SSSS) is as well called as Ritter von
Ritterschein disease, Lyell disease, Ritter disease and staphylococcal necrolysis of the …

[PDF][PDF] Leflunomide a rare culprit for drug induced subacute cutaneous lupus erythematosus

MN Mahesha, B Prashanthi, T Dinupa, NC Perera - slcd.lk
22 SLCD Case repor 81-83.pmd Page 1 81 Vol. 21, 2019 / 2020 Leflunomide a rare culprit for
drug induced subacute cutaneous lupus erythematosus Leflunomide a rare culprit for drug …

[HTML][HTML] Лікарсько-індукований червоний вовчак: сучасні дані про механізми розвитку та асоційовані лікарські препарати

ИЮ Головач, ЕД Егудина - rheumatology.kiev.ua
Лікарсько-індукований червоний вовчак (ЛІЧВ)—це автоімунний феномен, викликаний
певними лікарськими препаратами, який призводить до синдрому з характерними …

Lúpus eritematoso induzido por fármacos: revisão da literatura

FC Lé Côrte-Real - PQDT-Global, 2019 - search.proquest.com
O lúpus eritematoso induzido por medicamentos apresenta características clínicas,
serológicas e histopatológicas muito semelhantes às encontradas no lúpus eritematoso …

[PDF][PDF] Case Report on a Rare Adverse Drug Reaction of Cefotaxime Induced Subacute Cutaneous Lupus Erythematosus

KC Clement, N Nalini - Journal of Young Pharmacists, 2019 - jyoungpharm.org
Drug Induced lupus erythematosus is a variant of lupus erythematosus that resolves within
days to months after withdrawal of the culprit drug in a patient. DILE can sometimes arise …